NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Shengshan Asset Management

Shengshan Asset Management

Shanghai, Shanghaiwisdomont.com

Overview

Shengshan Asset Management is a venture capital and private equity firm based in Shanghai, China. It seeks to make investments in healthcare and TMT sectors .

Year Founded

2014

Portfolio Companies

14

Investments

Shengshan Asset Management investments
CompanyDateStageLead
Changing BiotechnologyJan 2023Series A ExtensionCo-investor
Konfoong Bioinformation Tech Co., Ltd.Jul 2022Series CLead
AceLink TherapeuticsMay 2021Series ACo-investor
上海黑焰医疗科技有限公司Apr 2021Series ALead
Shenzhen Genocury Biotechnology Co., Ltd.Nov 2020Series B ExtensionCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShanghai, Shanghai
Year Founded2014

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.